Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunity. 2012 Oct 19;37(4):634-48. doi: 10.1016/j.immuni.2012.06.020. Epub 2012 Oct 11.

The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells.

Author information

1
IMMH, Institute of Medical Microbiology and Hygiene, University of Freiburg, Germany.

Abstract

Innate lymphoid cells (ILCs) reside at mucosal surfaces and control immunity to intestinal infections. Type 2 innate lymphoid cells (ILC2s) produce cytokines such as IL-5 and IL-13, are required for immune defense against helminth infections, and are involved in the pathogenesis of airway hyperreactivity. Here, we have investigated the role of the transcription factor GATA-3 for ILC2 differentiation and maintenance. We showed that ILC2s and their lineage-specified bone marrow precursors (ILC2Ps), as identified here, were characterized by continuous high expression of GATA-3. Analysis of mice with temporary deletion of GATA-3 in all ILCs showed that GATA-3 was required for the differentiation and maintenance of ILC2s but not for RORγt(+) ILCs. Thus, our data demonstrate that GATA-3 is essential for ILC2 fate decisions and reveal similarities between the transcriptional programs controlling ILC and T helper cell fates.

PMID:
23063333
PMCID:
PMC3662874
DOI:
10.1016/j.immuni.2012.06.020
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center